CIDARA THERAPEUTICS, INC. Assets, Fair Value Disclosure
CIDARA THERAPEUTICS, INC. had Assets, Fair Value Disclosure of $516.91 million as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Notes › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2025-08-07
- 2025-06-30: Assets, Fair Value Disclosure $516.91M.
- 2025-03-31: Assets, Fair Value Disclosure $174.49M.
- 2024-12-31: Assets, Fair Value Disclosure $196.18M.
- 2024-09-30: Assets, Fair Value Disclosure $127.39M.
| Period end | Assets, Fair Value Disclosure | Assets, Fair Value Disclosure as first filed |
|---|---|---|
| 2025-06-30 | $516.91M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $174.49M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $196.18M 10-Q · filed 2025-08-07 | |
| 2024-09-30 | $127.39M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $164.37M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $29.02M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $35.78M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $48.67M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $50.43M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $47.98M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $32.73M 10-K · filed 2024-04-22 | |
| 2022-09-30 | $53.08M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $25.01M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $37.97M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $62.27M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $40.30M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $53.10M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $48.79M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $42.95M 10-K · filed 2022-03-07 | |
| 2020-09-30 | $53.67M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $64.08M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $74.31M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $60.27M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $73.17M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $44.32M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $56.76M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $74.56M 10-K · filed 2020-03-04 | $74.08M 10-K · filed 2019-02-28 |
| 2017-12-31 | $74.66M 10-K · filed 2019-02-28 |